OrthoPediatrics (NASDAQ:KIDS) Trading Up 6.1% – What’s Next?

OrthoPediatrics Corp. (NASDAQ:KIDS)’s share price traded up 6.1% on Tuesday . The company traded as high as $24.34 and last traded at $24.20. 91,979 shares changed hands during trading, a decline of 45% from the average session volume of 167,614 shares. The stock had previously closed at $22.81.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on KIDS shares. Needham & Company LLC reissued a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research note on Friday, November 8th. Truist Financial decreased their price target on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a research note on Monday, October 14th. Finally, JMP Securities restated a “market outperform” rating and set a $50.00 price objective on shares of OrthoPediatrics in a research report on Friday, September 13th.

OrthoPediatrics Stock Performance

The firm has a market capitalization of $640.86 million, a price-to-earnings ratio of -21.24 and a beta of 1.16. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. The stock’s 50-day moving average is $26.67 and its 200-day moving average is $29.42.

Institutional Investors Weigh In On OrthoPediatrics

A number of hedge funds and other institutional investors have recently bought and sold shares of KIDS. Quarry LP acquired a new stake in shares of OrthoPediatrics during the third quarter valued at about $25,000. International Assets Investment Management LLC raised its holdings in OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after buying an additional 966 shares during the last quarter. Quest Partners LLC acquired a new stake in OrthoPediatrics during the 2nd quarter worth approximately $34,000. EntryPoint Capital LLC grew its holdings in OrthoPediatrics by 56.9% during the 1st quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock worth $81,000 after acquiring an additional 1,009 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its position in OrthoPediatrics by 125.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after acquiring an additional 1,929 shares during the period. Institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.